| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
David M. Bronson is Director at CNMD.
David M. Bronson has 14 Form 4 filings on record from July 2015 to June 2026, all as Director at Conmed (CNMD), 2015–2026.
The 36 reported transactions were 23 option or other derivative awards, 11 option exercises and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $159K and no sales.
The largest open-market purchase was 1,350 shares of CNMD at an average $72.09 on May 13, 2024, about $97K. Twelve months later CNMD was down 18%.